Cargando…

Eph receptors as oncotargets

Detalles Bibliográficos
Autores principales:	Charmsaz, Sara, Boyd, Andrew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669840/ https://www.ncbi.nlm.nih.gov/pubmed/29137214 http://dx.doi.org/10.18632/oncotarget.21045

Ejemplares similares

Introducing, OncoTarget
Publicado: (2010)

MKK3 as oncotarget
por: Bossi, Gianluca
Publicado: (2016)

Akt-Girdin as oncotarget
por: Takahashi, Masahide, et al.
Publicado: (2015)

YAP as oncotarget in uveal melanoma
por: Yu, Fa-Xing, et al.
Publicado: (2014)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Invasive leader cells: metastatic oncotarget
por: Cheung, Kevin J., et al.
Publicado: (2014)

Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)

Librarians against scientists: Oncotarget’s lesson
por: Blagosklonny, Mikhail V.
Publicado: (2018)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

HPV: Immunology lessons from an ancient oncotarget
por: Krishna, Sri, et al.
Publicado: (2019)

Galectin-1 as an oncotarget in gliomas and melanomas
por: Lefranc, Florence, et al.
Publicado: (2011)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

DNp73: oncotarget in invasion and metastasis
por: Pützer, Brigitte M.
Publicado: (2013)

Neuropeptide G Protein-Coupled Receptors as Oncotargets
por: Moody, Terry W., et al.
Publicado: (2018)

Microbial Oncotarget: Bacterial-Produced Butyrate, Chemoprevention and Warburg Effect
por: Donohoe, Dallas R., et al.
Publicado: (2013)

Voltage-dependent K(+) channels as oncotargets in malignant gliomas
por: Lefranc, Florence, et al.
Publicado: (2012)

FOXP3-microRNA-146-NF-κB as oncotarget
por: Etikala, Deepa M., et al.
Publicado: (2015)

Glutathione peroxidases as oncotargets
por: Jiao, Yang, et al.
Publicado: (2017)

Deubiquitinating enzymes as oncotargets
por: McClurg, Urszula L., et al.
Publicado: (2015)

Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
por: Janes, Peter W., et al.
Publicado: (2011)

Breathing the air of mitochondrial respiration via an important oncotarget - mitochondrial glycerophosphate dehydrogenase (mGPDH)
por: Thakur, Shilpa, et al.
Publicado: (2019)

Eph receptors as therapeutic targets in glioblastoma
por: Day, B W, et al.
Publicado: (2014)

AXL is an oncotarget in human colorectal cancer
por: Martinelli, Erika, et al.
Publicado: (2015)

Oncotargeting G proteins: The Hippo in the room
por: Feng, Xiaodong, et al.
Publicado: (2014)

4E-BP1 as an oncotarget
por: She, Qing-Bai
Publicado: (2015)

Eph Receptors in Cancer
por: Arora, Sakshi, et al.
Publicado: (2023)

An integrated approach identifies new oncotargets in melanoma
por: Cecconi, Daniela, et al.
Publicado: (2017)

Liposomes and nanotechnology in drug development: focus on oncotargets
por: Kozako, Tomohiro, et al.
Publicado: (2012)

P62: An emerging oncotarget for osteolytic metastasis
por: Zhang, Jing, et al.
Publicado: (2016)

The inflammasome: an emerging therapeutic oncotarget for cancer prevention
por: Zhiyu, Wang, et al.
Publicado: (2016)

Addendum: Librarians against scientists: Oncotarget’s lesson
por: Blagosklonny, Mikhail V.
Publicado: (2018)

The pursuit of oncotargets through understanding defective cell regulation
por: Qiao, Meng, et al.
Publicado: (2010)

Glycoengineering of EphA4 Fc leads to a unique, long-acting and broad spectrum, Eph receptor therapeutic antagonist
por: Pegg, Cassandra L., et al.
Publicado: (2017)

Antibody Targeting of Eph Receptors in Cancer
por: Janes, Peter W., et al.
Publicado: (2020)

Caveolin-1, a stress-related oncotarget, in drug resistance
por: Wang, Zhiyu, et al.
Publicado: (2015)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?
por: Marqués, Marta, et al.
Publicado: (2022)

Simultaneous targeting of Eph receptors in glioblastoma
por: Ferluga, Sara, et al.
Publicado: (2016)

Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC
por: Zhang, Jin-zhi, et al.
Publicado: (2022)

PHF5A as a new OncoTarget and therapeutic prospects
por: Li, Xiaojiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7j5ivrt2lprjelcmp530mo9n9m